outbreak
novel
coronaviru
diseas
caus
viru
spread
rapidli
around
globe
past
month
viru
infect
case
mortal
rate
diseas
increas
exponenti
scientist
research
world
relentlessli
work
understand
new
viru
along
possibl
treatment
regimen
discov
activ
therapeut
agent
vaccin
urgent
requir
new
effect
medic
treat
diseas
caus
perform
studi
drug
alreadi
avail
market
use
diseas
acceler
clinic
recoveri
word
repurpos
exist
drug
vast
complex
drug
design
protocol
regard
clinic
trial
often
prohibit
develop
variou
new
drug
combin
epidem
diseas
limit
time
recent
remark
improv
comput
power
coupl
advanc
machin
learn
ml
technolog
util
revolution
drug
develop
process
consequ
detail
studi
use
ml
repurpos
therapeut
agent
urgent
requir
report
ml
model
base
bay
algorithm
accuraci
around
predict
drug
could
use
treatment
studi
predict
around
ten
fda
approv
commerci
drug
use
repurpos
among
suggest
antiretrovir
drug
atazanavir
drugbank
id
would
probabl
one
effect
drug
base
select
criterion
studi
help
clinic
scientist
select
identifi
test
therapeut
agent
treatment
ml
base
approach
drug
discoveri
report
futurist
smart
drug
design
strategi
commun
applic
recent
outbreak
novel
coronaviru
diseas
consid
pandem
threat
global
popul
coronavirus
belong
famili
virus
mainli
found
anim
recent
outbreak
transmit
human
new
coronaviru
term
sever
acut
respiratori
syndromerel
coronaviru
affect
countri
case
confirm
death
report
world
april
could
potenti
bring
major
challeng
global
healthcar
disastr
effect
global
economi
viru
contain
within
month
common
symptom
includ
cough
fever
short
breath
fatigu
etc
make
confus
patient
differenti
symptom
typic
cold
flu
report
suggest
viru
transmit
bodi
fluid
infect
patient
especi
contact
sneez
even
though
exact
reason
known
unfortun
drug
approv
regulatori
agenc
treat
infect
effort
ongo
war
foot
find
effect
drug
vaccin
treat
pandem
coronavirus
classifi
four
class
design
alpha
beta
gamma
delta
betacoronaviru
class
includ
sever
acut
respiratori
syndrom
viru
sarscov
middl
east
respiratori
syndrom
viru
merscov
viru
coronavirus
found
consider
larg
virus
singlestrand
positivesens
rna
genom
encapsul
insid
membran
envelop
protein
apprear
like
spike
protrud
surfac
spike
adher
onto
human
cell
certain
receptor
target
cell
undergo
structur
chang
let
viral
membran
fuse
cell
membran
viral
gene
enter
host
cell
produc
virus
recent
studi
show
like
viru
respons
sar
outbreak
spike
also
bind
receptor
human
cell
surfac
call
angiotensinconvert
enzym
like
sarscov
merscov
also
attack
lower
respiratori
system
caus
viral
pneumonia
howev
also
report
could
affect
gastrointestin
system
heart
kidney
liver
central
nervou
system
result
multipl
organ
failur
compil
medic
report
data
avail
patient
found
transmissiblecontagi
sarscov
rapid
develop
comput
aid
technolog
like
ml
base
artifici
intellig
ai
help
acceler
drug
develop
process
differ
diseas
advantag
ai
approach
like
ml
appli
learn
exampl
build
predict
model
even
understand
underli
biolog
process
limit
comput
simul
base
fundament
physic
model
expens
carri
away
anoth
advantag
ml
automat
learn
identifi
complex
pattern
categor
set
input
data
therebi
make
intellig
decis
base
independ
dataset
ml
accur
predict
drugtarget
interact
enorm
amount
complex
inform
studi
hydrophob
interact
ionic
interact
hydrogen
bond
van
der
waal
forc
etc
molecul
bioactiv
dataset
avail
numer
high
throughput
screen
deliv
use
mean
machin
learn
classifi
contain
binari
inform
activeinact
well
numer
valu
classifi
differ
compound
consider
huge
number
dataset
avail
biolog
activ
molecul
deriv
high
throughput
screen
allow
creat
predict
comput
model
studi
appli
machin
learn
approach
predict
sever
new
potenti
drug
treatment
valid
predict
drug
initi
train
model
inhibitor
sar
coronaviru
proteas
fda
approv
drug
taken
drug
bank
test
model
predict
new
drug
new
drug
valid
use
dock
method
ensur
drug
match
activ
site
protein
rank
list
drug
base
energi
valu
given
test
experiment
studi
hypothes
commerci
fda
approv
antiretrovir
drug
atazanavir
may
potenti
candid
requir
limit
viral
recognit
host
cell
disrupt
hostviru
interact
thu
requir
clinic
trial
present
studi
compound
dataset
test
cell
base
system
use
plate
reader
result
store
bioassay
dataset
pub
chem
dataset
pubchem
bioassay
assign
aid
contain
around
compound
one
activ
set
inhibitor
sar
coronaviru
proteas
cell
dataset
store
section
bioassay
pubchem
databas
nation
centr
biotechnolog
inform
ncbi
identif
aid
number
aid
correspond
bioassay
drug
bank
onlin
databas
contain
detail
data
variou
medic
today
wide
use
facilit
silico
drug
target
discoveri
drug
design
drug
dock
screen
drug
metabol
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
predict
drug
interact
predict
gener
pharmaceut
educ
databas
drug
categor
mani
differ
type
trial
stage
drug
approv
drug
withdrawn
drug
databas
drug
approv
variou
medic
purpos
research
focus
fda
approv
drug
repurpos
purpos
around
intent
minim
clinic
trial
present
situat
drug
download
form
sdf
process
descript
gener
taken
test
model
develop
train
model
made
basi
databas
contain
inhibitor
sar
coronaviru
develop
model
predict
potenti
drug
ncbi
protein
databas
use
process
get
fasta
sequenc
desir
protein
sar
coronaviru
fasta
sequenc
use
model
threedimension
protein
structur
basi
structur
dock
known
predict
drug
carri
sinc
dataset
present
form
sdf
gener
attribut
present
sdf
first
inform
present
sdf
gener
csv
file
use
train
dataset
test
dataset
prepar
ml
model
csv
file
contain
activ
inact
point
split
train
dataset
test
dataset
entir
split
process
random
process
done
selfwritten
python
code
split
per
condit
use
machin
learn
ml
model
select
dataset
pubchem
consid
inhibitor
test
drug
drug
bank
find
suitabl
drug
use
ml
implement
classif
algorithm
describ
classif
type
supervis
learn
comput
system
learn
dataset
contain
detail
practic
result
algorithm
procedur
classif
assign
input
valu
accord
descript
dataset
requir
mathemat
classifi
assign
specif
class
activ
inact
label
instanc
defin
attribut
process
train
model
made
learn
use
dataset
classif
alreadi
assign
basi
abl
run
differ
dataset
classifi
accord
present
instanc
studi
compar
result
classifi
bay
classif
algorithm
naiv
bayesian
classif
algorithm
simpl
eleg
approach
assum
classif
attribut
independ
nt
correl
type
classifi
depend
bay
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
hypothesi
naiv
bay
work
best
two
case
complet
independ
featur
expect
function
depend
featur
expect
wide
test
method
probabilist
induct
classifi
function
well
advantag
mani
induct
algorithm
entangl
iter
paramet
make
work
vast
data
set
algorithm
use
induct
algorithm
comput
speed
reliabl
use
binari
classif
well
multiclassif
train
model
prepar
origin
dataset
dataset
complet
classifi
comput
learn
find
relat
among
variou
attribut
crossvalid
use
along
algorithm
train
model
case
crossvalid
n
set
nfold
dataset
suppos
divid
train
dataset
n
part
part
use
train
data
one
use
valid
rest
process
iter
goe
n
iter
time
use
chosen
per
size
dataset
gener
dataset
contain
binari
classif
base
sever
attribut
imbalanc
observ
similar
tred
imbalanc
dataset
possibl
handl
normal
classifi
sinc
give
import
attribut
equal
could
lead
misclassif
error
decreas
accuraci
dataset
train
model
therefor
use
misclassif
cost
train
model
becom
cost
sensit
abl
find
lowest
expect
cost
approach
actual
much
random
neither
depend
upon
number
attribut
minor
class
ration
rather
depend
base
classifi
two
method
introduc
misclassif
cost
imbal
dataset
first
method
classifi
algorithm
costsensit
one
proceed
rest
set
use
wrapper
help
base
classifi
cost
sensit
one
use
bay
classifi
use
cost
insensit
algorithm
predict
probabl
estim
test
instanc
use
predict
class
label
exampl
test
dataset
report
classifi
dataset
two
class
ie
activ
inact
use
matrix
gener
use
binari
classif
matrix
section
true
posit
activ
classifi
activ
fals
posit
inact
classifi
activ
fals
neg
activ
classifi
inact
true
neg
inact
classifi
inact
case
percent
fals
neg
import
percent
fals
posit
upper
limit
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
fals
posit
set
process
increas
misclassif
set
percent
also
help
increas
true
posit
sinc
activ
less
number
replic
around
time
match
inact
make
model
less
bias
apart
bcr
mathew
correl
coeffici
mcc
also
use
whose
rang
vari
receiv
oper
characterist
roc
curv
visual
ratio
fpr
tpr
case
fpr
tpr
place
xand
yaxi
respectivel
area
curv
show
probabl
predict
classifi
abil
classifi
randomli
chosen
instanc
correct
class
around
drug
predict
ml
model
effect
treatment
diseas
caus
avail
drug
sinc
epidem
recent
acceler
case
april
predict
compound
confid
dock
use
patchdock
web
server
first
taken
inhibitor
nt
allow
replic
host
screen
collect
bioassay
aid
use
main
compon
model
train
model
use
ml
attribut
taken
consider
compound
use
unsupervis
learn
filter
dataset
would
made
dataset
much
weaker
mention
method
section
use
classifi
algorithm
train
model
best
among
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
use
test
predict
drug
drug
bank
schemat
process
shown
figur
result
compar
rest
dataset
found
way
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
better
satisfi
criteria
rest
algorithm
reach
mark
achiev
naiv
bay
model
creat
naiv
bay
algorithm
predict
around
drug
approv
drug
drug
contain
drug
may
treatment
diseas
caus
sar
predict
sever
drug
dock
suggest
top
keep
align
ml
accuraci
dock
result
dock
result
use
bind
energi
predict
effect
bind
compound
result
shown
tabl
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
pdb
structur
sarscov
proteas
retriev
protein
data
bank
pdb
id
intiti
strcute
optim
remov
water
moplecul
ligand
ligand
structrur
retriv
pubchem
http
pubchemncbinlmnihgov
dock
experi
done
patchdock
server
http
result
refin
energi
calcul
perform
per
algorithm
use
firedock
server
server
final
rank
perform
identifi
nearn
refin
solut
rank
base
variou
bind
energi
function
includ
varieti
energi
term
van
der
waal
interact
partial
electrostat
desolv
energi
atom
contact
energi
ace
hydrogen
disulfid
bond
pstack
aliphat
interact
rotam
probabl
result
minimum
global
energi
taken
consider
drug
predict
atazanavir
drugbank
id
figur
studi
taken
drug
dock
purpos
show
proteas
inhibit
activ
dock
sar
protein
approv
drug
atazanavir
drugbank
id
global
energi
around
kcalmol
confirm
numer
steric
clash
adjoin
strand
thu
highlight
potenti
inhibit
novel
sar
coronaviru
atazanavir
small
molecul
antiretrovir
drug
figur
addit
dock
drug
also
dock
sever
approv
drug
avail
drug
bank
predict
ml
model
confid
level
also
show
activ
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
proteas
inhibit
supplementari
inform
figur
refer
found
drug
predict
model
inclus
paramet
taken
consider
also
quit
effect
rapid
identif
activ
therapeut
agent
major
challeng
analyz
avail
knowledg
safeti
profil
case
efficaci
coronavirus
repurpos
exist
antivir
drug
potenti
crucial
shortterm
strategi
tackl
current
scenario
take
year
bring
drug
investig
stage
market
avail
trial
error
process
socal
edisonian
approach
one
keep
analyz
sever
compound
find
best
possibl
one
day
inclus
digit
medicin
time
span
reduc
great
extent
peopl
abl
approach
ration
manner
drug
discoveri
process
target
repurpss
drug
toward
develop
effect
treatment
speed
clinic
trial
found
ml
model
creat
basi
naiv
bay
algorithm
effect
one
accuraci
almost
equal
drug
predict
model
verifi
dock
process
specul
predict
drug
show
immens
potenti
treatment
consid
ongo
effort
prevent
spread
world
optimist
outbreak
may
subsid
month
like
sar
mer
howev
outbreak
stress
urgent
need
renew
effort
toward
develop
braodspectrum
therapeut
agent
combat
coronavirus
repeatedli
found
realist
threat
centuri
till
finding
provid
base
enhanc
drug
discoveri
program
author
contribut
sm
pn
execut
machin
learn
part
mc
nd
execut
dock
part
dk
pr
help
write
edit
manuscript
medic
input
ss
formul
problem
instruct
execut
method
mostli
written
edit
manuscript
scienc
technolog
govern
india
right
reserv
reus
allow
without
permiss
certifi
peer
review
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
